SPRAVATO®
(esketamine)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SPRAVATO® (esketamine)
Medical Information
Real-world safety profile of esketamine nasal spray during the first 12 treatment sessions: an analysis at 46 months after approval in the United States
Last updated: 10/06/2023